An FDA alert sent to health care professionals advised of an increased risk of suicidal ideation and behavior in patients receiving anticonvulsants.

Question

Quizplus · Accepted Answer

The FDA has issued warnings that anticonvulsants can increase the risk of suicidal thoughts and behavior in patients. This is based on analyses of clinical trials that showed patients taking these medications had a slightly higher risk of suicidal behavior or ideation compared to placebo.

An FDA Alert Sent to Health Care Professionals Advised of an Increased